feed,title,long_url,short_url
Benzinga,Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold,https://benzinga.com/general/biotech/22/09/28986729/pfizer-resumes-dosing-in-phase-3-hemophilia-gene-therapy-trial-six-months-after-fda-lifts-clinica,https://bit.ly/3SfCmPa
